|

Finding Patterns in Malignant Peritoneal Mesothelioma

ByHolly Zink
Finding Patterns in Malignant Peritoneal Mesothelioma

Researchers from the United States looked at malignant peritoneal mesothelioma (MPM) data over eighteen years for patterns in incidence and survival.

They found that the incidence of MPM cases was steady while survival rates have increased. More cancer-directed surgeries and better identification of cell types in MPM patients may be behind the improved survival rates.

Second Most Common Site

MPM is an aggressive disease caused by asbestos. The peritoneum is the space in your abdomen that contains the intestines, the stomach, and the liver. The abdomen (peritoneum) is the second most common site of mesothelioma after the pleural area (lungs and chest).

Most doctors believe MPM is caused by the ingestion of asbestos fibers. Microscopic asbestos fibers become embedded in the abdomen.

After about 20-50 years, these fibers can cause inflammation and mutations in healthy cells. These mutations may ultimately cause these cells to become cancerous.

MPM accounts for 20-25% of all mesothelioma cases. Patients with peritoneal mesothelioma have a longer life expectancy than those with other types of mesothelioma. And some studies report patients live up to 5 years after treatment.

Extended Survival Rates

One reason for these extended survival rates may be the development of better treatments for MPM.

Researchers from University of California and Ohio State University looked at MPM data from the SEER-18 registry. This registry is managed by the National Cancer Institute and is the largest data source on cancer in the United States.

The data covers MPM from 2000 to 2018. About 1,600 cases of MPM were identified during this eighteen-year period.

Over half of these cases were in men, and nearly three-quarters of the cases were Caucasian. Nearly 80% of the patients represented by this data were 50 years of age or older.

Cancer-directed surgery was performed in about 30% of MPM patients and increased over time.

The researchers noted an increase in the diagnosis of epithelioid MPM. This refers to the cell type of mesothelioma, which can have a big impact on treatment decisions and overall survival. They also noticed a decrease in cases of MPM with no identified cell type.

This means that doctors are getting better at identifying the cell type of MPM. They can make better treatment plans for MPM patients that lead to improved survival.

Source

Calthorpe L, Romero-Hernandez F, Miller P, et al. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States. Cancers (Basel). 2022;15(1):229. Published 2022 Dec 30. doi:10.3390/cancers15010229. https://www.mdpi.com/2072-6694/15/1/229#

Similar Posts

Does Radiotherapy Reduce Mesothelioma Pain?
| |

Does Radiotherapy Reduce Mesothelioma Pain?

ByAlex Strauss

A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

Website Aims to Protect Homeowners from Mesothelioma
|

Website Aims to Protect Homeowners from Mesothelioma

ByAlex Strauss

Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

Ape Virus Shrinks Mesothelioma Tumors in Lab
|

Ape Virus Shrinks Mesothelioma Tumors in Lab

ByAlex Strauss

A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

Mesothelioma Nurses Ready for New Cases in Australia
| | |

Mesothelioma Nurses Ready for New Cases in Australia

ByAlex Strauss

Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

Mesothelioma Victims’ Victory in Pennsylvania
|

Mesothelioma Victims’ Victory in Pennsylvania

ByAlex Strauss

Workers and their families have won a victory in Pennsylvania after the state Supreme Court ruled that they could sue former employers over late-manifesting industrial diseases like mesothelioma. The decision focused on a provision in Pennsylvania’s Workers’ Compensation Act that says workers cannot sue an employer if their occupational disease occurred more than 300 weeks after their on-the-job exposure. While many occupational injuries and diseases occur within weeks or months of exposure to a toxin, asbestos diseases like mesothelioma are a notable exception. Believed to be caused by chronic irritation from inhaled or ingested asbestos fibers, mesothelioma does not usually begin to cause symptoms until at least a decade after exposure. Expressing the opinion of the majority, Supreme Court Justice…

Chemical in Wine May Improve Mesothelioma Treatment
|

Chemical in Wine May Improve Mesothelioma Treatment

ByAlex Strauss

There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…